News & Articles

The award money will help to expand Nanotrap Particle manufacturing capacity for COVID-19 testing

The agreement is part of preparations for GMP production of material for the first clinical study of CG01

New research published in Nature Immunology show strong T cell responses in patients recovered from COVID-19

CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO

New test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus

Test to be integrated in over 5,000 DiaSorin analyzers, allowing physicians to differentiate between bacterial and viral infections

Sanofi and GSK are scaling up the manufacturing of the antigen and adjuvant with the target of producing up to one billion doses in 2021

Following successful evaluation by The Liverpool School of Tropical Medicine, the ELISA test will now be made available for COVID-19 researchers

Data shows 100% concordance with results from Dartmouth-Hitchcock’s lab-based polymerase chain reaction (PCR) test method

An analytical breakthrough that could significantly improve our chances of finding extra-terrestrial life in our galaxy

Rapid increase in production of VTM and saline will help boost virus testing

A new prognostic tool developed by an international team led by CTI-Bath paves the way for personalized medicine for cancer patients

The new AI technology will learn from past CT scans of COVID-19 pneumonia patients, reducing the burden on doctors making diagnoses

FoundationOne Liquid CDx analyzes more than 300 cancer-related genes and multiple genomic signatures to inform treatment decisions for all solid tumor cancers

Combining image analysis with structured reporting, the software aims to improve and accelerate the detection of the virus